SEC 13F Intelligence

Oppenheimer & Co Inc / AMGN

Oppenheimer & Co Inc’s Amgen Inc Position

Does Oppenheimer & Co Inc own Amgen Inc (AMGN)? Yes — 119.8K shares worth $42M (+0.51% of its 13F portfolio) as of Q1 2026, up from 113.1K shares the prior filed quarter.

Position Value
$42M
Q1 2026
Shares
119.8K
% of Portfolio
+0.51%
Quarters Held
29
currently held

Position History AMGN

Reported value by quarter
Q4 ’18: $24MQ4 ’18Q1 ’19: $24MQ2 ’19: $20MQ3 ’19: $22MQ4 ’19: $27MQ4 ’19Q1 ’20: $23MQ2 ’20: $23MQ3 ’20: $21MQ4 ’20: $19MQ4 ’20Q1 ’21: $23MQ2 ’21: $23MQ3 ’21: $20MQ4 ’21: $22MQ4 ’21Q1 ’22: $23MQ2 ’22: $23MQ3 ’22: $21MQ4 ’22: $23MQ4 ’22Q1 ’23: $25MQ2 ’23: $24MQ3 ’23: $29MQ4 ’23: $32MQ4 ’23Q1 ’24: $34MQ2 ’24: $39MQ3 ’24: $39MQ4 ’24: $29MQ4 ’24Q1 ’25: $34MQ2 ’25: $31MQ3 ’25: $32MQ1 ’26: $42MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026119.8K$42M+0.51%
Q3 2025113.1K$32M+0.39%
Q2 2025111.0K$31M+0.41%
Q1 2025109.8K$34M+0.52%
Q4 2024111.2K$29M+0.43%
Q3 2024122.6K$39M+0.60%
Q2 2024123.6K$39M+0.61%
Q1 2024121.2K$34M+0.57%
Q4 2023112.3K$32M+0.59%
Q3 2023108.9K$29M+0.60%
Q2 2023106.2K$24M+0.47%
Q1 2023104.5K$25M+0.54%
Q4 202287.6K$23M+0.52%
Q3 202293.9K$21M+0.49%
Q2 202292.5K$23M+0.48%
Q1 202295.3K$23M+0.42%
Q4 202197.4K$22M+0.38%
Q3 202192.7K$20M+0.37%
Q2 202194.0K$23M+0.41%
Q1 202192.5K$23M+0.46%
Q4 202082.6K$19M+0.40%
Q3 202083.4K$21M+0.53%
Q2 202096.5K$23M+0.59%
Q1 2020113.8K$23M+0.70%
Q4 2019110.2K$27M+0.66%
Q3 2019111.9K$22M+0.59%
Q2 2019111.2K$20M+0.56%
Q1 2019124.6K$24M+0.63%
Q4 2018125.2K$24M+0.76%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Oppenheimer & Co Inc’s full portfolio or all institutional holders of AMGN.